US Congress House Bill 8479 (Prior Session Legislation)

---

Spectrum: Bipartisan Bill
Status: Introduced on October 1 2020 - 25% progression, died in committee
Action: 2020-10-01 - Referred to the House Committee on Energy and Commerce.
Pending: House Energy And Commerce Committee
Text: Latest bill text (Introduced) [PDF]

Requires the Department of Health and Human Services (HHS) to create a pilot program with private entities to test the effectiveness of acquiring, maintaining, managing, and distributing a stockpile of generic drugs at risk of shortage. Specifically, HHS must enter into contracts of up to three years for entities to create a six-month stockpile of up to 50 types of such drugs. The bill establishes various program requirements, including annual evaluations by the Government Accountability Office.

Essential Medicines Strategic Stockpile Act of 2020

Rep. Earl Carter [R-GA]

Rep. Lisa Rochester [D-DE]

Date	Chamber	Action
2020-10-01	House	Referred to the House Committee on Energy and Commerce.
2020-10-01	House	Introduced in House

HB14 (Related) 2020-11-02 - Referred to the Subcommittee on Railroads, Pipelines, and Hazardous Materials.

Type	Source
Summary	https://www.congress.gov/bill/116th-congress/house-bill/8479/all-info
Text	https://www.congress.gov/116/bills/hr8479/BILLS-116hr8479ih.pdf